InvestorsHub Logo
Followers 79
Posts 24434
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 04/18/2017 8:39:37 AM

Tuesday, April 18, 2017 8:39:37 AM

Post# of 27336
CLRB - 2.08 Pre-market now at 2.30/2.38

Cellectar Biosciences Receives Japanese Patent for CLR 131 and CLR 125 for the Treatment of Cancer Stem Cells



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.